2020 treatment algorithm for multiple myeloma and conclusions (part 5 of 5 - imf ash 2019 satellite)
Published 4 years ago • 5.5K plays • Length 13:14Download video MP4
Download video MP3
Similar videos
-
23:47
evolution of upfront therapy for the asct-ineligible patient (pt 2 of 5 - imf ash 2019 satellite)
-
17:54
proposed 2019 treatment algorithms for mm
-
53:40
the current therapeutic landscape for relapsed or refractory mm (pt 4 of 5 - imf ash 2019 satellite)
-
36:29
upfront therapy for the asct-eligible patient: (pt. 3 of 5 - imf ash satellite)
-
58:48
best of ash 2019
-
5:19
a 17-year fight against multiple myeloma
-
1:02:01
top myeloma research presented at asco & eha 2024
-
36:40
what a newly diagnosed patient needs to know
-
4:13
what can newly diagnosed myeloma patients expect in regard to treatment in 2020?
-
28:51
diagnosis and risk stratification of plasma cell disorders (pt 1 of 5 - imf ash satellite)
-
13:27
patient & family seminar 2024 | advancements in myeloma treatment strategies: multiple drugs upfront
-
56:41
approaches to relapse therapy in multiple myeloma: recent advancements and treatment strategies
-
46:17
myeloma experts address new treatments, financial considerations, early detection, & management.
-
13:19
using the immune system to fight multiple myeloma
-
1:23
standards of care for myeloma patients | ash 2020
-
5:20
myeloma university | monoclonal antibodies as treatment for multiple myeloma
-
2:29
outcomes in multiple myeloma based on comorbidities and race
-
5:16
updated risk stratification model for smoldering multiple myeloma
-
4:00
top multiple myeloma research presented at ash 2018
-
18:32
updates in multiple myeloma from asco 2020
-
29:25
multiple myeloma treatment: induction, car t, managing side effects and maintaining quality of life
-
2:45
top multiple myeloma abstracts presented at ash 2019